ÂÜÀòÂÒÂ×

Adam Hayet is a finance professional with extensive experience in financial planning and analysis, currently serving as Senior Manager of Financial Planning and Analysis at BridgeBio since November 2020. In this role, Adam acts as a finance business partner for Gene Therapy and Oncology affiliates, managing budgets and reforecasts, while overseeing Gene Therapy CDMO agreements. Prior to BridgeBio, Adam held positions at Catalent Pharma Solutions and Paragon Bioservices, where responsibilities included developing annual operating budgets, forecasting financial metrics, and supporting executive teams in financial reporting and M&A activities. Adam began the career with Aerotek, contributing to financial analysis and revenue management. Adam holds an MBA in Management from Loyola University Maryland and a Bachelor's degree in Marketing from Towson University.